Adhish P. Patil, Chief Financial Officer of Aarti Drugs, said the company expects utilisation at the facility to rise to 80-85% within the next two quarters, which should significantly improve gross contribution.
Adhish P. Patil, Chief Financial Officer of Aarti Drugs, said the company expects utilisation at the facility to rise to 80-85% within the next two quarters, which should significantly improve gross contribution.
<iframe src="https://hindustansphere.com/embed/cluster/9c18970669c4aa709b68816ac41a45a9448dee1f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Aarti Drugs Targets 15-16% EBITDA Margin On Higher Sayakha Utilisation, Metformin Volumes: CFO"></iframe>
